Quantcast
Home > Quotes > GTXI
GTXI

GTx, Inc. Common Stock (GTXI) Quote & Summary Data

$1.3632
*  
0.1068
7.27%
Get GTXI Alerts
*Delayed - data as of Nov. 14, 2018 14:28 ET  -  Find a broker to begin trading GTXI now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    GTXI Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 1.36 / $ 1.37
1 Year Target
1.75
Today's High / Low
$ 1.48 / $ 1.336
Share Volume
381,646
50 Day Avg. Daily Volume
2,837,001
Previous Close
$ 1.47
52 Week High / Low
$ 25.60 / $ 1.32
Market Cap
32,787,474
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.98

Intraday Chart

Shares Traded

Share Volume:
381,646
50 Day Avg. Daily Volume:
2,837,001

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -1.87

Trading Range

The current last sale of $1.3632 is 3.27% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 1.48 $ 25.60
 Low: $ 1.336 $ 1.32

Company Description (as filed with the SEC)

We are a biopharmaceutical company dedicated to the discovery, development and commercialization of medicines to treat serious and/or significant unmet medical conditions, including stress urinary incontinence and prostate cancer. Our current strategy is focused on the further development of selective androgen receptor modulators, or SARMs, a class of drugs that we believe has the potential to treat serious medical conditions where unmet medical needs in muscle-related diseases may benefit from increasing muscle mass, such as stress urinary incontinence, or SUI.  ... More ...  


Risk Grade

Where does GTXI fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 1.48
Open Date:
Nov. 14, 2018
Close Price:
$ 1.47
Close Date:
Nov. 13, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x